Our Commitment
Extensive expertise in the analysis of biological samples for both clinical and non-clinical studies
Uncompromising Quality, Compliance, and Data Integrity
Timely and Accurate Analysis & Reporting Supporting Decision-Making and Research Efforts
Expert Bioanalytic Services for Regulated Biomarker Studies
Expert Bioanalytic Services for Regulated Biomarker Studies
Nicotine Pharmacokinetic Analysis for Regulatory Submissions
Nicotine Pharmacokinetic Analysis for Regulatory Submissions
Trusted Bioanalytical Services Tailored to Your Specific Application
Trusted Bioanalytical Services Tailored to Your Specific Application
Integrated Solutions for Seamless Sample Management World Wide
Integrated Solutions for Seamless Sample Management World Wide
Biomarker
|
Exposure to
|
Matrix
|
Analytical Technique
| Reference |
---|---|---|---|---|
1,3-Butadiene | Tobacco Smoke | ETS | GC-MS | |
1-Aminonaphthalene (1-AN) | 1-Aminonaphthalene | Urine | GC-MS |
publication
April 2006
Determination of three carcinogenic aromatic amines in urine of smokers and nonsmokersRiedel K, Scherer G, Engl J, Hagedorn H-W, Tricker AR Journal of Analytical Toxicology, Volume 30, doi: 10.1093/jat/30.3.187
publication
November 2022
Assessment of the Exposure to Aromatic Amines in Users of Various Tobacco/Nicotine ProductsGerhard Scherer, Kirsten Riedel, Nikola Pluym, Max Scherer ACS Omega, doi: 10.1021/acsomega.2c06130 |
1-Hydroxyphenanthrene (1-OH-Phe) | Phenanthrene | Urine | LC-MS/MS |
publication
February 2020
Polycyclic aromatic hydrocarbons (PAH) in urine of children and adolescents in Germany - human biomonitoring results of the German Environmental Survey 2014-2017 (GerES V)Murawski A, Roth A, Schwedler G, Schmied-Tobies MIH, Rucic E, Pluym N, Scherer M, Scherer G, Conrad A, Kolossa-Gehring M International Journal of Hygiene and Environmental Health, Volume 226, doi: 10.1016/j.ijheh.2020.113491
publication
November 2010
A liquid chromatography/tandem mass spectrometry (LC-MS/MS) method for the determination of phenolic polycyclic aromatic hydrocarbons (OH-PAH) in urine of non-smokers and smokersRamsauer B, Sterz K, Hagedorn H-W, Engl J, Scherer G, McEwan M, Errington G, Shepperd J, Cheung F Analytical and Bioanalytical Chemistry, volume 399, doi:10.1007/s00216-010-4355-7
publication
August 2022
Assessment of the exposure to polycyclic aromatic hydrocarbons in users of various tobacco/nicotine products by suitable urinary biomarkersGerhard Scherer, Max Scherer, Nadine Rögner, Nikola Pluym Archives of Toxicology doi.org/10.1007/s00204-022-03349-4
Conference contribution
September 2022
The impact of European legislation on the reduction of Environmental Tobacco Smoke and Polycyclic Aromatic Hydrocarbons between 1995 and 2019 in GermanyTherese Burkhardt, Max Scherer, Gerhard Scherer, Till Weber, Nikola Pluym, Marike Kolossa-Gehring ISES 2022, Lisbon
publication
October 2022
Time trend of exposure to secondhand tobacco smoke and polycyclic aromatic hydrocarbons between 1995 and 2019 in Germany – Showcases for successful European legislationTherese Burkhardt, Max Scherer, Gerhard Scherer, Nikola Pluym, Till Weber, Marike Kolossa-Gehring Environmental Research, doi: 10.1016/j.envres.2022.114638 |
1-Hydroxypyrene (1-OH-Pyr) | Pyrene | Urine | LC-MS/MS |
publication
February 2020
Polycyclic aromatic hydrocarbons (PAH) in urine of children and adolescents in Germany - human biomonitoring results of the German Environmental Survey 2014-2017 (GerES V)Murawski A, Roth A, Schwedler G, Schmied-Tobies MIH, Rucic E, Pluym N, Scherer M, Scherer G, Conrad A, Kolossa-Gehring M International Journal of Hygiene and Environmental Health, Volume 226, doi: 10.1016/j.ijheh.2020.113491
publication
November 2010
A liquid chromatography/tandem mass spectrometry (LC-MS/MS) method for the determination of phenolic polycyclic aromatic hydrocarbons (OH-PAH) in urine of non-smokers and smokersRamsauer B, Sterz K, Hagedorn H-W, Engl J, Scherer G, McEwan M, Errington G, Shepperd J, Cheung F Analytical and Bioanalytical Chemistry, volume 399, doi:10.1007/s00216-010-4355-7
publication
August 2022
Assessment of the exposure to polycyclic aromatic hydrocarbons in users of various tobacco/nicotine products by suitable urinary biomarkersGerhard Scherer, Max Scherer, Nadine Rögner, Nikola Pluym Archives of Toxicology doi.org/10.1007/s00204-022-03349-4
Conference contribution
September 2022
The impact of European legislation on the reduction of Environmental Tobacco Smoke and Polycyclic Aromatic Hydrocarbons between 1995 and 2019 in GermanyTherese Burkhardt, Max Scherer, Gerhard Scherer, Till Weber, Nikola Pluym, Marike Kolossa-Gehring ISES 2022, Lisbon
publication
October 2022
Time trend of exposure to secondhand tobacco smoke and polycyclic aromatic hydrocarbons between 1995 and 2019 in Germany – Showcases for successful European legislationTherese Burkhardt, Max Scherer, Gerhard Scherer, Nikola Pluym, Till Weber, Marike Kolossa-Gehring Environmental Research, doi: 10.1016/j.envres.2022.114638 |
1-Naphthol (1-Hydroxynaphthalene, 1-OH-Nap) | Naphthalene | Urine | LC-MS/MS |
publication
February 2020
Polycyclic aromatic hydrocarbons (PAH) in urine of children and adolescents in Germany - human biomonitoring results of the German Environmental Survey 2014-2017 (GerES V)Murawski A, Roth A, Schwedler G, Schmied-Tobies MIH, Rucic E, Pluym N, Scherer M, Scherer G, Conrad A, Kolossa-Gehring M International Journal of Hygiene and Environmental Health, Volume 226, doi: 10.1016/j.ijheh.2020.113491
publication
November 2010
A liquid chromatography/tandem mass spectrometry (LC-MS/MS) method for the determination of phenolic polycyclic aromatic hydrocarbons (OH-PAH) in urine of non-smokers and smokersRamsauer B, Sterz K, Hagedorn H-W, Engl J, Scherer G, McEwan M, Errington G, Shepperd J, Cheung F Analytical and Bioanalytical Chemistry, volume 399, doi:10.1007/s00216-010-4355-7
publication
August 2022
Assessment of the exposure to polycyclic aromatic hydrocarbons in users of various tobacco/nicotine products by suitable urinary biomarkersGerhard Scherer, Max Scherer, Nadine Rögner, Nikola Pluym Archives of Toxicology doi.org/10.1007/s00204-022-03349-4
Conference contribution
September 2022
The impact of European legislation on the reduction of Environmental Tobacco Smoke and Polycyclic Aromatic Hydrocarbons between 1995 and 2019 in GermanyTherese Burkhardt, Max Scherer, Gerhard Scherer, Till Weber, Nikola Pluym, Marike Kolossa-Gehring ISES 2022, Lisbon
publication
October 2022
Time trend of exposure to secondhand tobacco smoke and polycyclic aromatic hydrocarbons between 1995 and 2019 in Germany – Showcases for successful European legislationTherese Burkhardt, Max Scherer, Gerhard Scherer, Nikola Pluym, Till Weber, Marike Kolossa-Gehring Environmental Research, doi: 10.1016/j.envres.2022.114638 |
11-dehydro-TXB2 | Inflammation | Urine | LC-MS/MS |
publication
April 2018
Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature reviewScherer G Regulatory Toxicology and Pharmacology, Volume 94, doi: 10.1016/j.yrtph.2018.02.002
publication
March 2018
Analysis of Urinary Eicosanoids by LC-MS/MS Reveals Alterations in the Metabolic Profile after Smoking CessationGoettel M, Niessner R, Scherer M, Scherer G, Pluym N Chemical Research in Toxicology, Volume 31, doi: 10.1021/acs.chemrestox
publication
October 2017
Metabolomic Fingerprinting in Various Body Fluids of a Diet-Controlled Clinical Smoking Cessation Study Using a Validated GC-TOF-MS Metabolomics PlatformGoettel M, Niessner R, Mueller D, Scherer M, Scherer G, Pluym N Journal of Proteome Research, Volume 16(10), doi: 10.1021/acs.jproteome.7b00128.
publication
January 2018
Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco productsPeck MJ, Sanders EB, Scherer G, Luedicke F, Weitkunat R Biomarkers, Volume 23(3), doi: 10.1080/1354750X.2017.1419284
publication
February 2012
A simple and robust UPLC-SRM/MS method to quantify urinary eicosanoidsSterz K, Scherer G, Ecker J Journal of Lipid Research, Volume 53, doi: 10.1194/jlr.D023739
Conference contribution
October 2018
Identifying suitable biomarkers of biological effects (BOBEs) for evaluating reduced risk productsScherer G, Pluym N, Scherer M CORESTA Congress 2018, Biomarker Workshop, Kunming, China |
12(S)-HETE | Inflammation | Urine | LC-MS/MS |
publication
April 2018
Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature reviewScherer G Regulatory Toxicology and Pharmacology, Volume 94, doi: 10.1016/j.yrtph.2018.02.002
publication
March 2018
Analysis of Urinary Eicosanoids by LC-MS/MS Reveals Alterations in the Metabolic Profile after Smoking CessationGoettel M, Niessner R, Scherer M, Scherer G, Pluym N Chemical Research in Toxicology, Volume 31, doi: 10.1021/acs.chemrestox
publication
October 2017
Metabolomic Fingerprinting in Various Body Fluids of a Diet-Controlled Clinical Smoking Cessation Study Using a Validated GC-TOF-MS Metabolomics PlatformGoettel M, Niessner R, Mueller D, Scherer M, Scherer G, Pluym N Journal of Proteome Research, Volume 16(10), doi: 10.1021/acs.jproteome.7b00128.
publication
February 2012
A simple and robust UPLC-SRM/MS method to quantify urinary eicosanoidsSterz K, Scherer G, Ecker J Journal of Lipid Research, Volume 53, doi: 10.1194/jlr.D023739 |
2,3-dinor-8-iso-PGF2α | Oxidative Stress | Urine | LC-MS/MS |
publication
April 2018
Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature reviewScherer G Regulatory Toxicology and Pharmacology, Volume 94, doi: 10.1016/j.yrtph.2018.02.002
publication
March 2018
Analysis of Urinary Eicosanoids by LC-MS/MS Reveals Alterations in the Metabolic Profile after Smoking CessationGoettel M, Niessner R, Scherer M, Scherer G, Pluym N Chemical Research in Toxicology, Volume 31, doi: 10.1021/acs.chemrestox
publication
October 2017
Metabolomic Fingerprinting in Various Body Fluids of a Diet-Controlled Clinical Smoking Cessation Study Using a Validated GC-TOF-MS Metabolomics PlatformGoettel M, Niessner R, Mueller D, Scherer M, Scherer G, Pluym N Journal of Proteome Research, Volume 16(10), doi: 10.1021/acs.jproteome.7b00128.
publication
February 2012
A simple and robust UPLC-SRM/MS method to quantify urinary eicosanoidsSterz K, Scherer G, Ecker J Journal of Lipid Research, Volume 53, doi: 10.1194/jlr.D023739 |
2,3-dinor-TXB2 | Inflammation | Urine | LC-MS/MS |
publication
April 2018
Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature reviewScherer G Regulatory Toxicology and Pharmacology, Volume 94, doi: 10.1016/j.yrtph.2018.02.002
publication
March 2018
Analysis of Urinary Eicosanoids by LC-MS/MS Reveals Alterations in the Metabolic Profile after Smoking CessationGoettel M, Niessner R, Scherer M, Scherer G, Pluym N Chemical Research in Toxicology, Volume 31, doi: 10.1021/acs.chemrestox
publication
October 2017
Metabolomic Fingerprinting in Various Body Fluids of a Diet-Controlled Clinical Smoking Cessation Study Using a Validated GC-TOF-MS Metabolomics PlatformGoettel M, Niessner R, Mueller D, Scherer M, Scherer G, Pluym N Journal of Proteome Research, Volume 16(10), doi: 10.1021/acs.jproteome.7b00128.
publication
January 2018
Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco productsPeck MJ, Sanders EB, Scherer G, Luedicke F, Weitkunat R Biomarkers, Volume 23(3), doi: 10.1080/1354750X.2017.1419284
publication
February 2012
A simple and robust UPLC-SRM/MS method to quantify urinary eicosanoidsSterz K, Scherer G, Ecker J Journal of Lipid Research, Volume 53, doi: 10.1194/jlr.D023739
Conference contribution
October 2018
Identifying suitable biomarkers of biological effects (BOBEs) for evaluating reduced risk productsScherer G, Pluym N, Scherer M CORESTA Congress 2018, Biomarker Workshop, Kunming, China |
2-(Carboxyl-1-methylethyl)mercapturic acid (CMEMA) | Crotonaldehyde | Urine | LC-MS/MS |
publication
May 2015
Analysis of 18 urinary mercapturic acids by two high-throughput multiplex-LC-MS/MS methodsPluym N, Gilch G, Scherer G, Scherer M Analytical and Bioanalytical Chemistry, Volume 407, doi: 10.1007/s00216-015-8719-x
Conference contribution
October 2014
Analysis of 18 Urinary Mercapturic Acids by two Multiplex-LC-MS/MS MethodsPluym N, Gilch G, Scherer G, Scherer M CORESTA Congress 2014, Quebec, Canada
publication
October 2022
Comparison of urinary mercapturic acid excretions in users of various tobacco/nicotine productsGerhard Scherer, Nikola Pluym, Max Scherer Drug Testing and Analysis DOI: 10.1002/dta.3372 |
2-Aminonaphthalene (2-AN) | 2-Aminonaphthalene | Urine, ETS | GC-MS |
publication
April 2006
Determination of three carcinogenic aromatic amines in urine of smokers and nonsmokersRiedel K, Scherer G, Engl J, Hagedorn H-W, Tricker AR Journal of Analytical Toxicology, Volume 30, doi: 10.1093/jat/30.3.187
publication
November 2022
Assessment of the Exposure to Aromatic Amines in Users of Various Tobacco/Nicotine ProductsGerhard Scherer, Kirsten Riedel, Nikola Pluym, Max Scherer ACS Omega, doi: 10.1021/acsomega.2c06130 |
2-Hydroxy-1-phenylethylmercapturic acid (PHEMA 1) | Styrene | Urine | LC-MS/MS |
publication
May 2015
Analysis of 18 urinary mercapturic acids by two high-throughput multiplex-LC-MS/MS methodsPluym N, Gilch G, Scherer G, Scherer M Analytical and Bioanalytical Chemistry, Volume 407, doi: 10.1007/s00216-015-8719-x
Conference contribution
October 2014
Analysis of 18 Urinary Mercapturic Acids by two Multiplex-LC-MS/MS MethodsPluym N, Gilch G, Scherer G, Scherer M CORESTA Congress 2014, Quebec, Canada
publication
October 2022
Comparison of urinary mercapturic acid excretions in users of various tobacco/nicotine productsGerhard Scherer, Nikola Pluym, Max Scherer Drug Testing and Analysis DOI: 10.1002/dta.3372 |
2-Hydroxy-2-phenylethylmercapturic acid (PHEMA 2) | Styrene | Urine | LC-MS/MS |
publication
May 2015
Analysis of 18 urinary mercapturic acids by two high-throughput multiplex-LC-MS/MS methodsPluym N, Gilch G, Scherer G, Scherer M Analytical and Bioanalytical Chemistry, Volume 407, doi: 10.1007/s00216-015-8719-x
Conference contribution
October 2014
Analysis of 18 Urinary Mercapturic Acids by two Multiplex-LC-MS/MS MethodsPluym N, Gilch G, Scherer G, Scherer M CORESTA Congress 2014, Quebec, Canada
publication
October 2022
Comparison of urinary mercapturic acid excretions in users of various tobacco/nicotine productsGerhard Scherer, Nikola Pluym, Max Scherer Drug Testing and Analysis DOI: 10.1002/dta.3372 |
2-Hydroxyethylmercapturic acid (HEMA) | Ethylene oxide, Alkylating agents | Urine | LC-MS/MS |
publication
May 2015
Analysis of 18 urinary mercapturic acids by two high-throughput multiplex-LC-MS/MS methodsPluym N, Gilch G, Scherer G, Scherer M Analytical and Bioanalytical Chemistry, Volume 407, doi: 10.1007/s00216-015-8719-x
Conference contribution
October 2014
Analysis of 18 Urinary Mercapturic Acids by two Multiplex-LC-MS/MS MethodsPluym N, Gilch G, Scherer G, Scherer M CORESTA Congress 2014, Quebec, Canada
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–resultsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients – methodsLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2018
Analytical methods for the determination of carbonyls in aerosol from e-vapor products and cigarette smoke and their urinary biomarkers of exposureLandmesser A, Scherer M, Scherer G, Pluym N CORESTA Congress 2018, Kunming, China
publication
October 2022
Comparison of urinary mercapturic acid excretions in users of various tobacco/nicotine productsGerhard Scherer, Nikola Pluym, Max Scherer Drug Testing and Analysis DOI: 10.1002/dta.3372 |
2-Hydroxyfluorene (2-OH-Flu) | Fluorene | Urine | LC-MS/MS |
publication
February 2020
Polycyclic aromatic hydrocarbons (PAH) in urine of children and adolescents in Germany - human biomonitoring results of the German Environmental Survey 2014-2017 (GerES V)Murawski A, Roth A, Schwedler G, Schmied-Tobies MIH, Rucic E, Pluym N, Scherer M, Scherer G, Conrad A, Kolossa-Gehring M International Journal of Hygiene and Environmental Health, Volume 226, doi: 10.1016/j.ijheh.2020.113491
publication
November 2010
A liquid chromatography/tandem mass spectrometry (LC-MS/MS) method for the determination of phenolic polycyclic aromatic hydrocarbons (OH-PAH) in urine of non-smokers and smokersRamsauer B, Sterz K, Hagedorn H-W, Engl J, Scherer G, McEwan M, Errington G, Shepperd J, Cheung F Analytical and Bioanalytical Chemistry, volume 399, doi:10.1007/s00216-010-4355-7
publication
August 2022
Assessment of the exposure to polycyclic aromatic hydrocarbons in users of various tobacco/nicotine products by suitable urinary biomarkersGerhard Scherer, Max Scherer, Nadine Rögner, Nikola Pluym Archives of Toxicology doi.org/10.1007/s00204-022-03349-4
Conference contribution
September 2022
The impact of European legislation on the reduction of Environmental Tobacco Smoke and Polycyclic Aromatic Hydrocarbons between 1995 and 2019 in GermanyTherese Burkhardt, Max Scherer, Gerhard Scherer, Till Weber, Nikola Pluym, Marike Kolossa-Gehring ISES 2022, Lisbon |
2-Hydroxyphenanthrene (2-OH-Phe) | Phenanthrene | Urine | LC-MS/MS |
publication
February 2020
Polycyclic aromatic hydrocarbons (PAH) in urine of children and adolescents in Germany - human biomonitoring results of the German Environmental Survey 2014-2017 (GerES V)Murawski A, Roth A, Schwedler G, Schmied-Tobies MIH, Rucic E, Pluym N, Scherer M, Scherer G, Conrad A, Kolossa-Gehring M International Journal of Hygiene and Environmental Health, Volume 226, doi: 10.1016/j.ijheh.2020.113491
publication
November 2010
A liquid chromatography/tandem mass spectrometry (LC-MS/MS) method for the determination of phenolic polycyclic aromatic hydrocarbons (OH-PAH) in urine of non-smokers and smokersRamsauer B, Sterz K, Hagedorn H-W, Engl J, Scherer G, McEwan M, Errington G, Shepperd J, Cheung F Analytical and Bioanalytical Chemistry, volume 399, doi:10.1007/s00216-010-4355-7
publication
August 2022
Assessment of the exposure to polycyclic aromatic hydrocarbons in users of various tobacco/nicotine products by suitable urinary biomarkersGerhard Scherer, Max Scherer, Nadine Rögner, Nikola Pluym Archives of Toxicology doi.org/10.1007/s00204-022-03349-4
Conference contribution
September 2022
The impact of European legislation on the reduction of Environmental Tobacco Smoke and Polycyclic Aromatic Hydrocarbons between 1995 and 2019 in GermanyTherese Burkhardt, Max Scherer, Gerhard Scherer, Till Weber, Nikola Pluym, Marike Kolossa-Gehring ISES 2022, Lisbon
publication
October 2022
Time trend of exposure to secondhand tobacco smoke and polycyclic aromatic hydrocarbons between 1995 and 2019 in Germany – Showcases for successful European legislationTherese Burkhardt, Max Scherer, Gerhard Scherer, Nikola Pluym, Till Weber, Marike Kolossa-Gehring Environmental Research, doi: 10.1016/j.envres.2022.114638 |
2-Hydroxypropylmercapturic acid (2-HPMA) | Propylene oxide | Urine | LC-MS/MS |
publication
May 2015
Analysis of 18 urinary mercapturic acids by two high-throughput multiplex-LC-MS/MS methodsPluym N, Gilch G, Scherer G, Scherer M Analytical and Bioanalytical Chemistry, Volume 407, doi: 10.1007/s00216-015-8719-x
Conference contribution
October 2014
Analysis of 18 Urinary Mercapturic Acids by two Multiplex-LC-MS/MS MethodsPluym N, Gilch G, Scherer G, Scherer M CORESTA Congress 2014, Quebec, Canada
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–resultsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients – methodsLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2018
Novel biomarkers to characterize exposure to aldehydes from e-vapor products based on stable-isotope constituentsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N CORESTA Congress 2018, Kunming, China
Conference contribution
October 2018
Analytical methods for the determination of carbonyls in aerosol from e-vapor products and cigarette smoke and their urinary biomarkers of exposureLandmesser A, Scherer M, Scherer G, Pluym N CORESTA Congress 2018, Kunming, China
Conference contribution
October 2019
Analysis of aldehydes, propylene oxide and glycidol in tobacco smoke and e-cigarette vapor and their respective urinary biomarkersLandmesser A, Scherer G, Pluym N, Scherer M CORESTA SSPT 2019, Hamburg, Germany
Conference contribution
February 2018
Biomarkers of exposure specific to e-vapor products based on stable-isotope labeled ingredientsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N SRNT 2018, Baltimore, USA
Conference contribution
February 2019
Novel biomarkers to characterize the specific exposure to aldehydes or epoxides from e-vapor products based on stable-isotope labeled constituentsLandmesser A, Scherer M, Scherer G, Pluym N SRNT 2019, San Francisco, USA
publication
June 2021
Assessment of the potential vaping-related exposure to carbonyls and epoxides using stable isotope-labeled precursors in the e-liquidLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Niessner R, Pluym N Archives of Toxicology, doi:10.1007/s00204-021-03097-x
publication
October 2022
Comparison of urinary mercapturic acid excretions in users of various tobacco/nicotine productsGerhard Scherer, Nikola Pluym, Max Scherer Drug Testing and Analysis DOI: 10.1002/dta.3372 |
2-Naphthol (2-Hydroxynaphthalene, 2-OH-Nap) | Naphthalene | Urine | LC-MS/MS |
publication
February 2020
Polycyclic aromatic hydrocarbons (PAH) in urine of children and adolescents in Germany - human biomonitoring results of the German Environmental Survey 2014-2017 (GerES V)Murawski A, Roth A, Schwedler G, Schmied-Tobies MIH, Rucic E, Pluym N, Scherer M, Scherer G, Conrad A, Kolossa-Gehring M International Journal of Hygiene and Environmental Health, Volume 226, doi: 10.1016/j.ijheh.2020.113491
publication
November 2010
A liquid chromatography/tandem mass spectrometry (LC-MS/MS) method for the determination of phenolic polycyclic aromatic hydrocarbons (OH-PAH) in urine of non-smokers and smokersRamsauer B, Sterz K, Hagedorn H-W, Engl J, Scherer G, McEwan M, Errington G, Shepperd J, Cheung F Analytical and Bioanalytical Chemistry, volume 399, doi:10.1007/s00216-010-4355-7
publication
August 2022
Assessment of the exposure to polycyclic aromatic hydrocarbons in users of various tobacco/nicotine products by suitable urinary biomarkersGerhard Scherer, Max Scherer, Nadine Rögner, Nikola Pluym Archives of Toxicology doi.org/10.1007/s00204-022-03349-4
Conference contribution
September 2022
The impact of European legislation on the reduction of Environmental Tobacco Smoke and Polycyclic Aromatic Hydrocarbons between 1995 and 2019 in GermanyTherese Burkhardt, Max Scherer, Gerhard Scherer, Till Weber, Nikola Pluym, Marike Kolossa-Gehring ISES 2022, Lisbon
publication
October 2022
Time trend of exposure to secondhand tobacco smoke and polycyclic aromatic hydrocarbons between 1995 and 2019 in Germany – Showcases for successful European legislationTherese Burkhardt, Max Scherer, Gerhard Scherer, Nikola Pluym, Till Weber, Marike Kolossa-Gehring Environmental Research, doi: 10.1016/j.envres.2022.114638 |
20-Carboxy-Leukotriene B4 | Inflammation | Urine | LC-MS/MS |
publication
April 2018
Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature reviewScherer G Regulatory Toxicology and Pharmacology, Volume 94, doi: 10.1016/j.yrtph.2018.02.002
publication
October 2017
Metabolomic Fingerprinting in Various Body Fluids of a Diet-Controlled Clinical Smoking Cessation Study Using a Validated GC-TOF-MS Metabolomics PlatformGoettel M, Niessner R, Mueller D, Scherer M, Scherer G, Pluym N Journal of Proteome Research, Volume 16(10), doi: 10.1021/acs.jproteome.7b00128. |
20-Hydroxy-Leukotriene B4 | Inflammation | Urine | LC-MS/MS |
publication
April 2018
Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature reviewScherer G Regulatory Toxicology and Pharmacology, Volume 94, doi: 10.1016/j.yrtph.2018.02.002
publication
October 2017
Metabolomic Fingerprinting in Various Body Fluids of a Diet-Controlled Clinical Smoking Cessation Study Using a Validated GC-TOF-MS Metabolomics PlatformGoettel M, Niessner R, Mueller D, Scherer M, Scherer G, Pluym N Journal of Proteome Research, Volume 16(10), doi: 10.1021/acs.jproteome.7b00128. |
3-Aminobiphenyl (3-ABP) | 3-Aminobiphenyl | Urine | GC-MS |
publication
April 2006
Determination of three carcinogenic aromatic amines in urine of smokers and nonsmokersRiedel K, Scherer G, Engl J, Hagedorn H-W, Tricker AR Journal of Analytical Toxicology, Volume 30, doi: 10.1093/jat/30.3.187
publication
November 2022
Assessment of the Exposure to Aromatic Amines in Users of Various Tobacco/Nicotine ProductsGerhard Scherer, Kirsten Riedel, Nikola Pluym, Max Scherer ACS Omega, doi: 10.1021/acsomega.2c06130 |
3-Ethenylpyridine | Tobacco Smoke | Environmental Tobacco Smoke (ETS) | GC-MS | |
3-Hydroxy-1-methylpropylmercapturic acid (HMPMA) | Crotonaldehyde | Urine | LC-MS/MS |
publication
May 2015
Analysis of 18 urinary mercapturic acids by two high-throughput multiplex-LC-MS/MS methodsPluym N, Gilch G, Scherer G, Scherer M Analytical and Bioanalytical Chemistry, Volume 407, doi: 10.1007/s00216-015-8719-x
Conference contribution
October 2014
Analysis of 18 Urinary Mercapturic Acids by two Multiplex-LC-MS/MS MethodsPluym N, Gilch G, Scherer G, Scherer M CORESTA Congress 2014, Quebec, Canada
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–resultsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients – methodsLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
publication
June 2021
Assessment of the potential vaping-related exposure to carbonyls and epoxides using stable isotope-labeled precursors in the e-liquidLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Niessner R, Pluym N Archives of Toxicology, doi:10.1007/s00204-021-03097-x
publication
October 2022
Comparison of urinary mercapturic acid excretions in users of various tobacco/nicotine productsGerhard Scherer, Nikola Pluym, Max Scherer Drug Testing and Analysis DOI: 10.1002/dta.3372 |
3-Hydroxyphenanthrene (3-OH-Phe) | Phenanthrene | Urine | LC-MS/MS |
publication
February 2020
Polycyclic aromatic hydrocarbons (PAH) in urine of children and adolescents in Germany - human biomonitoring results of the German Environmental Survey 2014-2017 (GerES V)Murawski A, Roth A, Schwedler G, Schmied-Tobies MIH, Rucic E, Pluym N, Scherer M, Scherer G, Conrad A, Kolossa-Gehring M International Journal of Hygiene and Environmental Health, Volume 226, doi: 10.1016/j.ijheh.2020.113491
publication
November 2010
A liquid chromatography/tandem mass spectrometry (LC-MS/MS) method for the determination of phenolic polycyclic aromatic hydrocarbons (OH-PAH) in urine of non-smokers and smokersRamsauer B, Sterz K, Hagedorn H-W, Engl J, Scherer G, McEwan M, Errington G, Shepperd J, Cheung F Analytical and Bioanalytical Chemistry, volume 399, doi:10.1007/s00216-010-4355-7
publication
August 2022
Assessment of the exposure to polycyclic aromatic hydrocarbons in users of various tobacco/nicotine products by suitable urinary biomarkersGerhard Scherer, Max Scherer, Nadine Rögner, Nikola Pluym Archives of Toxicology doi.org/10.1007/s00204-022-03349-4
Conference contribution
September 2022
The impact of European legislation on the reduction of Environmental Tobacco Smoke and Polycyclic Aromatic Hydrocarbons between 1995 and 2019 in GermanyTherese Burkhardt, Max Scherer, Gerhard Scherer, Till Weber, Nikola Pluym, Marike Kolossa-Gehring ISES 2022, Lisbon
publication
October 2022
Time trend of exposure to secondhand tobacco smoke and polycyclic aromatic hydrocarbons between 1995 and 2019 in Germany – Showcases for successful European legislationTherese Burkhardt, Max Scherer, Gerhard Scherer, Nikola Pluym, Till Weber, Marike Kolossa-Gehring Environmental Research, doi: 10.1016/j.envres.2022.114638 |
3-Hydroxypropylmercapturic acid (3-HPMA) | Acrolein | Urine | LC-MS/MS |
publication
May 2015
Analysis of 18 urinary mercapturic acids by two high-throughput multiplex-LC-MS/MS methodsPluym N, Gilch G, Scherer G, Scherer M Analytical and Bioanalytical Chemistry, Volume 407, doi: 10.1007/s00216-015-8719-x
Conference contribution
October 2014
Analysis of 18 Urinary Mercapturic Acids by two Multiplex-LC-MS/MS MethodsPluym N, Gilch G, Scherer G, Scherer M CORESTA Congress 2014, Quebec, Canada
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–resultsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients – methodsLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2018
Novel biomarkers to characterize exposure to aldehydes from e-vapor products based on stable-isotope constituentsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N CORESTA Congress 2018, Kunming, China
Conference contribution
October 2018
Analytical methods for the determination of carbonyls in aerosol from e-vapor products and cigarette smoke and their urinary biomarkers of exposureLandmesser A, Scherer M, Scherer G, Pluym N CORESTA Congress 2018, Kunming, China
Conference contribution
October 2019
Analysis of aldehydes, propylene oxide and glycidol in tobacco smoke and e-cigarette vapor and their respective urinary biomarkersLandmesser A, Scherer G, Pluym N, Scherer M CORESTA SSPT 2019, Hamburg, Germany
Conference contribution
February 2018
Biomarkers of exposure specific to e-vapor products based on stable-isotope labeled ingredientsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N SRNT 2018, Baltimore, USA
Conference contribution
February 2019
Novel biomarkers to characterize the specific exposure to aldehydes or epoxides from e-vapor products based on stable-isotope labeled constituentsLandmesser A, Scherer M, Scherer G, Pluym N SRNT 2019, San Francisco, USA
publication
June 2021
Assessment of the potential vaping-related exposure to carbonyls and epoxides using stable isotope-labeled precursors in the e-liquidLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Niessner R, Pluym N Archives of Toxicology, doi:10.1007/s00204-021-03097-x
publication
October 2022
Comparison of urinary mercapturic acid excretions in users of various tobacco/nicotine productsGerhard Scherer, Nikola Pluym, Max Scherer Drug Testing and Analysis DOI: 10.1002/dta.3372 |
3-Nitrotyrosine | Nitrosative stress | Plasma | LC-MS/MS | |
3-hydroxybenzo[a]pyrene (3-OH-BaP) | Benzo[a]pyrene | Urine | LC-MS/MS |
Conference contribution
June 2021
Analysis of 3-hydroxybenzo[a]pyrene in urine as a biomarker of exposure for benzo[a]pyrene in smokers and users of potentially reduced risk productsRögner N, Scherer M, Scherer G, Pluym N Global Forum on Nicotine 2021, Virtual
publication
October 2021
A Sensitive LC–MS/MS Method for the Quantification of 3-Hydroxybenzo[a]pyrene in Urine-Exposure Assessment in Smokers and Users of Potentially Reduced-Risk ProductsRögner N, Hagedorn H-W, Scherer G, Scherer M, Pluym N Separations, 8(10), 171, doi: 10.3390/separations8100171
Conference contribution
October 2021
Analysis of 3-hydroxybenzo[a]pyrene in urine as a biomarker of exposure for benzo[a]pyrene in smokers and users of potentially reduced risk productsScherer M, Rögner N, Scherer G, Pluym N CORESTA SSPT 2021, Virtual
publication
October 2022
Time trend of exposure to secondhand tobacco smoke and polycyclic aromatic hydrocarbons between 1995 and 2019 in Germany – Showcases for successful European legislationTherese Burkhardt, Max Scherer, Gerhard Scherer, Nikola Pluym, Till Weber, Marike Kolossa-Gehring Environmental Research, doi: 10.1016/j.envres.2022.114638 |
4-Aminobiphenyl (4-ABP) | 4-Aminobiphenyl | Urine, ETS | GC-MS |
publication
April 2014
A correlation study applied to biomarkers of internal and effective dose for acrylonitrile and 4-aminobiphenyl in smokersScherer G, Newland K, Papadopoulou E, Minet E Biomarkers, Volume 19(4), doi: 10.3109/1354750X.2014.910271
publication
April 2006
Determination of three carcinogenic aromatic amines in urine of smokers and nonsmokersRiedel K, Scherer G, Engl J, Hagedorn H-W, Tricker AR Journal of Analytical Toxicology, Volume 30, doi: 10.1093/jat/30.3.187
publication
November 2022
Assessment of the Exposure to Aromatic Amines in Users of Various Tobacco/Nicotine ProductsGerhard Scherer, Kirsten Riedel, Nikola Pluym, Max Scherer ACS Omega, doi: 10.1021/acsomega.2c06130 |
4-Hydroxy-4-(3-pyridyl)butanoic acid (HyPyBut) | Nicotine | Urine | LC-MS/MS |
publication
March 2019
Biomarkers of Exposure Specific to E-vapor Products Based on Stable-Isotope Labeled IngredientsLandmesser A, Scherer M, Pluym N, Sarkar M, Edmiston J, Niessner R, Scherer G Nicotine & Tobacco Research, Volume 21, doi: 10.1093/ntr/nty204
publication
May 2018
Collaborative Method Performance Study of the Measurement of Nicotine, Its Metabolites, and Total Nicotine Equivalents in Human UrineWang L, Bernert JT, Benowitz NL, Feng J, Jacob P 3rd, McGahee E, Caudill SP, Scherer G, Scherer M, Pluym N, Doig MV, Newland K, Murphy SE, Caron NJ, Sander LC, Shimizu M, Yamazaki H, Kim S, Langman LJ, Pritchett JS, Sniegoski LT, Li Y, Blount BC, Pirkle JL Cancer Epidemiology, Biomarkers & Prevention, Volume 27, doi: 10.1158/1055-9965
publication
January 2014
Simple, fast and sensitive LC-MS/MS analysis for the simultaneous quantification of nicotine and 10 of its major metabolitesPiller M, Gilch G, Scherer G, Scherer M Journal of Chromatography B, Volumes 951–952, doi: 10.1016/j.jchromb.2014.01.025
Conference contribution
October 2013
Assessing the exposure to ‘smoke’ from electronic cigarettes by biomarkersScherer G, Hagedorn H-W, Riedel K, Scherer M CORESTA SSPT 2013, Seville, Spain
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–study designLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–resultsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients – methodsLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
February 2018
Biomarkers of exposure specific to e-vapor products based on stable-isotope labeled ingredientsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N SRNT 2018, Baltimore, USA
publication
March 2022
Assessment of nicotine delivery and uptake in users of various tobacco / nicotine productsScherer G, Mütze J, Pluym N, Scherer M Current Research in Toxicology, Volume 3, 100067 |
4-Hydroxyphenanthrene (4-OH-Phe) | Phenanthrene | Urine | LC-MS/MS |
publication
February 2020
Polycyclic aromatic hydrocarbons (PAH) in urine of children and adolescents in Germany - human biomonitoring results of the German Environmental Survey 2014-2017 (GerES V)Murawski A, Roth A, Schwedler G, Schmied-Tobies MIH, Rucic E, Pluym N, Scherer M, Scherer G, Conrad A, Kolossa-Gehring M International Journal of Hygiene and Environmental Health, Volume 226, doi: 10.1016/j.ijheh.2020.113491
publication
November 2010
A liquid chromatography/tandem mass spectrometry (LC-MS/MS) method for the determination of phenolic polycyclic aromatic hydrocarbons (OH-PAH) in urine of non-smokers and smokersRamsauer B, Sterz K, Hagedorn H-W, Engl J, Scherer G, McEwan M, Errington G, Shepperd J, Cheung F Analytical and Bioanalytical Chemistry, volume 399, doi:10.1007/s00216-010-4355-7
publication
August 2022
Assessment of the exposure to polycyclic aromatic hydrocarbons in users of various tobacco/nicotine products by suitable urinary biomarkersGerhard Scherer, Max Scherer, Nadine Rögner, Nikola Pluym Archives of Toxicology doi.org/10.1007/s00204-022-03349-4
Conference contribution
September 2022
The impact of European legislation on the reduction of Environmental Tobacco Smoke and Polycyclic Aromatic Hydrocarbons between 1995 and 2019 in GermanyTherese Burkhardt, Max Scherer, Gerhard Scherer, Till Weber, Nikola Pluym, Marike Kolossa-Gehring ISES 2022, Lisbon
publication
October 2022
Time trend of exposure to secondhand tobacco smoke and polycyclic aromatic hydrocarbons between 1995 and 2019 in Germany – Showcases for successful European legislationTherese Burkhardt, Max Scherer, Gerhard Scherer, Nikola Pluym, Till Weber, Marike Kolossa-Gehring Environmental Research, doi: 10.1016/j.envres.2022.114638 |
8-Hydroxy-deoxyguanosine (8-OH-dG) | Oxidative stress | Urine | LC-MS/MS |
publication
April 2018
Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature reviewScherer G Regulatory Toxicology and Pharmacology, Volume 94, doi: 10.1016/j.yrtph.2018.02.002
publication
October 2017
Metabolomic Fingerprinting in Various Body Fluids of a Diet-Controlled Clinical Smoking Cessation Study Using a Validated GC-TOF-MS Metabolomics PlatformGoettel M, Niessner R, Mueller D, Scherer M, Scherer G, Pluym N Journal of Proteome Research, Volume 16(10), doi: 10.1021/acs.jproteome.7b00128.
Conference contribution
October 2018
Identifying suitable biomarkers of biological effects (BOBEs) for evaluating reduced risk productsScherer G, Pluym N, Scherer M CORESTA Congress 2018, Biomarker Workshop, Kunming, China |
8-iso-PGF2α | Oxidative Stress | Urine | LC-MS/MS |
publication
April 2018
Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature reviewScherer G Regulatory Toxicology and Pharmacology, Volume 94, doi: 10.1016/j.yrtph.2018.02.002
publication
March 2018
Analysis of Urinary Eicosanoids by LC-MS/MS Reveals Alterations in the Metabolic Profile after Smoking CessationGoettel M, Niessner R, Scherer M, Scherer G, Pluym N Chemical Research in Toxicology, Volume 31, doi: 10.1021/acs.chemrestox
publication
October 2017
Metabolomic Fingerprinting in Various Body Fluids of a Diet-Controlled Clinical Smoking Cessation Study Using a Validated GC-TOF-MS Metabolomics PlatformGoettel M, Niessner R, Mueller D, Scherer M, Scherer G, Pluym N Journal of Proteome Research, Volume 16(10), doi: 10.1021/acs.jproteome.7b00128.
publication
January 2018
Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco productsPeck MJ, Sanders EB, Scherer G, Luedicke F, Weitkunat R Biomarkers, Volume 23(3), doi: 10.1080/1354750X.2017.1419284
publication
February 2012
A simple and robust UPLC-SRM/MS method to quantify urinary eicosanoidsSterz K, Scherer G, Ecker J Journal of Lipid Research, Volume 53, doi: 10.1194/jlr.D023739
Conference contribution
October 2018
Identifying suitable biomarkers of biological effects (BOBEs) for evaluating reduced risk productsScherer G, Pluym N, Scherer M CORESTA Congress 2018, Biomarker Workshop, Kunming, China |
9-Hydroxyphenanthrene (9-OH-Phe) | Phenanthrene | Urine | LC-MS/MS |
publication
February 2020
Polycyclic aromatic hydrocarbons (PAH) in urine of children and adolescents in Germany - human biomonitoring results of the German Environmental Survey 2014-2017 (GerES V)Murawski A, Roth A, Schwedler G, Schmied-Tobies MIH, Rucic E, Pluym N, Scherer M, Scherer G, Conrad A, Kolossa-Gehring M International Journal of Hygiene and Environmental Health, Volume 226, doi: 10.1016/j.ijheh.2020.113491
publication
November 2010
A liquid chromatography/tandem mass spectrometry (LC-MS/MS) method for the determination of phenolic polycyclic aromatic hydrocarbons (OH-PAH) in urine of non-smokers and smokersRamsauer B, Sterz K, Hagedorn H-W, Engl J, Scherer G, McEwan M, Errington G, Shepperd J, Cheung F Analytical and Bioanalytical Chemistry, volume 399, doi:10.1007/s00216-010-4355-7
publication
August 2022
Assessment of the exposure to polycyclic aromatic hydrocarbons in users of various tobacco/nicotine products by suitable urinary biomarkersGerhard Scherer, Max Scherer, Nadine Rögner, Nikola Pluym Archives of Toxicology doi.org/10.1007/s00204-022-03349-4
Conference contribution
September 2022
The impact of European legislation on the reduction of Environmental Tobacco Smoke and Polycyclic Aromatic Hydrocarbons between 1995 and 2019 in GermanyTherese Burkhardt, Max Scherer, Gerhard Scherer, Till Weber, Nikola Pluym, Marike Kolossa-Gehring ISES 2022, Lisbon
publication
October 2022
Time trend of exposure to secondhand tobacco smoke and polycyclic aromatic hydrocarbons between 1995 and 2019 in Germany – Showcases for successful European legislationTherese Burkhardt, Max Scherer, Gerhard Scherer, Nikola Pluym, Till Weber, Marike Kolossa-Gehring Environmental Research, doi: 10.1016/j.envres.2022.114638 |
Acetaldehyde (FA) | Tobacco Smoke, E-Vapor Aerosol | ETS, e-liquids, aerosol | LC-MS/MS |
publication
June 2021
Assessment of the potential vaping-related exposure to carbonyls and epoxides using stable isotope-labeled precursors in the e-liquidLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Niessner R, Pluym N Archives of Toxicology, doi:10.1007/s00204-021-03097-x |
Acetone | Tobacco Smoke, E-Vapor Aerosol | ETS, e-liquids, aerosol | LC-MS/MS |
publication
June 2021
Assessment of the potential vaping-related exposure to carbonyls and epoxides using stable isotope-labeled precursors in the e-liquidLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Niessner R, Pluym N Archives of Toxicology, doi:10.1007/s00204-021-03097-x |
Acrolein (ACR) | Tobacco Smoke, E-Vapor Aerosol | ETS, e-liquids, aerosol | LC-MS/MS |
publication
June 2021
Assessment of the potential vaping-related exposure to carbonyls and epoxides using stable isotope-labeled precursors in the e-liquidLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Niessner R, Pluym N Archives of Toxicology, doi:10.1007/s00204-021-03097-x |
Acrylamidemercapturic acid (AAMA) | Acrylamide | Urine | LC-MS/MS |
publication
October 2020
Benzene metabolite SPMA and acrylamide metabolites AAMA and GAMA in urine of children and adolescents in Germany - human biomonitoring results of the German Environmental Survey 2014-2017 (GerES V)Schwedler G, Murawski A, Schmied-Tobies MIH, Rucic E, Scherer M, Pluym N, Scherer G, Bethke R, Kolossa-Gehring M Environmental Research, Volume 192, doi: 10.1016/j.envres.2020.110295
publication
May 2015
Analysis of 18 urinary mercapturic acids by two high-throughput multiplex-LC-MS/MS methodsPluym N, Gilch G, Scherer G, Scherer M Analytical and Bioanalytical Chemistry, Volume 407, doi: 10.1007/s00216-015-8719-x
publication
March 2006
Urinary Mercapturic Acids and a Hemoglobin Adduct for the Dosimetry of Acrylamide Exposure in Smokers and NonsmokersUrban M, Kavvadias D, Riedel K, Scherer G, Tricker AR Inhalation Toxicology, Volume 18, doi: 10.1080/08958370600748430
Conference contribution
October 2014
Analysis of 18 Urinary Mercapturic Acids by two Multiplex-LC-MS/MS MethodsPluym N, Gilch G, Scherer G, Scherer M CORESTA Congress 2014, Quebec, Canada
publication
October 2022
Comparison of urinary mercapturic acid excretions in users of various tobacco/nicotine productsGerhard Scherer, Nikola Pluym, Max Scherer Drug Testing and Analysis DOI: 10.1002/dta.3372 |
Anabasine (AB) | Anabasine | Plasma, Urine | LC-MS/MS |
publication
March 2022
Assessment of the Exposure to Tobacco-Specific Nitrosamines and Minor Tobacco Alkaloids in Users of Various Tobacco/Nicotine ProductsScherer G, Scherer M, Mütze J, Hauke T, Pluym N Chemical Research in Toxicology, doi: 10.1021/acs.chemrestox.2c00020 |
Anatabine (AT) | Anatabine | Plasma, Urine | LC-MS/MS |
publication
March 2022
Assessment of the Exposure to Tobacco-Specific Nitrosamines and Minor Tobacco Alkaloids in Users of Various Tobacco/Nicotine ProductsScherer G, Scherer M, Mütze J, Hauke T, Pluym N Chemical Research in Toxicology, doi: 10.1021/acs.chemrestox.2c00020 |
Benzene | Tobacco Smoke | ETS | GC-MS | |
Benzo[a]pyrene (BaP) | PAH | ETS | GC-MS | |
Benzo[a]pyrene tetrol (BaP-tetrol) | Benzo[a]pyrene | Urine | GC-MS/MS |
publication
March 2024
A sensitive GC–MS/MS method for the quantification of benzo[a]pyrene tetrol in urineFabian Pilz, Antonia Gärtner, Nikola Pluym, Gerhard Scherer, Max Scherer Analytical and Bioanalytical Chemistry |
Citronellol | Flavor | Urine | HS-SPME-GC-MS |
Conference contribution
October 2015
Determination of flavors and their metabolites in e-liquids and biological fluids - Identification of biomarkers of exposure to prominent e-cigarette flavorsRiedel K, Pluym N, Scherer G, Scherer M CORESTA SSPT 2015, Jeju, South Korea |
Cotinine | Nicotine | Urine, Plasma, Serum, Saliva | LC-MS/MS |
publication
March 2019
Biomarkers of Exposure Specific to E-vapor Products Based on Stable-Isotope Labeled IngredientsLandmesser A, Scherer M, Pluym N, Sarkar M, Edmiston J, Niessner R, Scherer G Nicotine & Tobacco Research, Volume 21, doi: 10.1093/ntr/nty204
publication
May 2018
Collaborative Method Performance Study of the Measurement of Nicotine, Its Metabolites, and Total Nicotine Equivalents in Human UrineWang L, Bernert JT, Benowitz NL, Feng J, Jacob P 3rd, McGahee E, Caudill SP, Scherer G, Scherer M, Pluym N, Doig MV, Newland K, Murphy SE, Caron NJ, Sander LC, Shimizu M, Yamazaki H, Kim S, Langman LJ, Pritchett JS, Sniegoski LT, Li Y, Blount BC, Pirkle JL Cancer Epidemiology, Biomarkers & Prevention, Volume 27, doi: 10.1158/1055-9965
publication
March 2014
Saliva as a matrix for human biomonitoring in occupational and environmental medicineMichalke B, Rossbach B, Göen T, Schäferhenrich A, Scherer G International Archives of Occupational and Environmental Health, volume 88, doi: 10.1007/s00420-014-0938-5
publication
January 2014
Simple, fast and sensitive LC-MS/MS analysis for the simultaneous quantification of nicotine and 10 of its major metabolitesPiller M, Gilch G, Scherer G, Scherer M Journal of Chromatography B, Volumes 951–952, doi: 10.1016/j.jchromb.2014.01.025
publication
February 2014
Untargeted metabolomic profiling in saliva of smokers and nonsmokers by a validated GC-TOF-MS methodMueller DC, Piller M, Niessner R, Scherer M, Scherer G Journal of Proteome Research, Volume 13, doi: 10.1021/pr401099r
Conference contribution
October 2013
Assessing the exposure to ‘smoke’ from electronic cigarettes by biomarkersScherer G, Hagedorn H-W, Riedel K, Scherer M CORESTA SSPT 2013, Seville, Spain
Conference contribution
October 2016
Ultra-sensitive method for the determination of nicotine in PK studies with next generation productsWanderer F, Pluym N, Scherer G, Scherer M CORESTA Congress 2016, Berlin, Germany
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–study designLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–resultsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients – methodsLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
February 2018
Biomarkers of exposure specific to e-vapor products based on stable-isotope labeled ingredientsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N SRNT 2018, Baltimore, USA
publication
March 2022
Assessment of nicotine delivery and uptake in users of various tobacco / nicotine productsScherer G, Mütze J, Pluym N, Scherer M Current Research in Toxicology, Volume 3, 100067
publication
September 2022
Urinary cotinine and exposure to passive smoke in children and adolescents in Germany – Human biomonitoring results of the German Environmental Survey 2014–2017 (GerES V)Domenica Hahn, Maria Schmied-Tobies, Enrico Rucic, Nikola Pluym, Max Scherer, Malgorzata Debiak, Aline Murawski, Marike Kolossa-Gehring Environmental Research doi.org/10.1016/j.envres.2022.114320
Conference contribution
September 2022
The impact of European legislation on the reduction of Environmental Tobacco Smoke and Polycyclic Aromatic Hydrocarbons between 1995 and 2019 in GermanyTherese Burkhardt, Max Scherer, Gerhard Scherer, Till Weber, Nikola Pluym, Marike Kolossa-Gehring ISES 2022, Lisbon
publication
October 2022
Time trend of exposure to secondhand tobacco smoke and polycyclic aromatic hydrocarbons between 1995 and 2019 in Germany – Showcases for successful European legislationTherese Burkhardt, Max Scherer, Gerhard Scherer, Nikola Pluym, Till Weber, Marike Kolossa-Gehring Environmental Research, doi: 10.1016/j.envres.2022.114638 |
Cotinine-N-oxide (CNO) | Nicotine | Urine | LC-MS/MS |
publication
March 2019
Biomarkers of Exposure Specific to E-vapor Products Based on Stable-Isotope Labeled IngredientsLandmesser A, Scherer M, Pluym N, Sarkar M, Edmiston J, Niessner R, Scherer G Nicotine & Tobacco Research, Volume 21, doi: 10.1093/ntr/nty204
publication
May 2018
Collaborative Method Performance Study of the Measurement of Nicotine, Its Metabolites, and Total Nicotine Equivalents in Human UrineWang L, Bernert JT, Benowitz NL, Feng J, Jacob P 3rd, McGahee E, Caudill SP, Scherer G, Scherer M, Pluym N, Doig MV, Newland K, Murphy SE, Caron NJ, Sander LC, Shimizu M, Yamazaki H, Kim S, Langman LJ, Pritchett JS, Sniegoski LT, Li Y, Blount BC, Pirkle JL Cancer Epidemiology, Biomarkers & Prevention, Volume 27, doi: 10.1158/1055-9965
publication
January 2014
Simple, fast and sensitive LC-MS/MS analysis for the simultaneous quantification of nicotine and 10 of its major metabolitesPiller M, Gilch G, Scherer G, Scherer M Journal of Chromatography B, Volumes 951–952, doi: 10.1016/j.jchromb.2014.01.025
Conference contribution
October 2013
Assessing the exposure to ‘smoke’ from electronic cigarettes by biomarkersScherer G, Hagedorn H-W, Riedel K, Scherer M CORESTA SSPT 2013, Seville, Spain
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–study designLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–resultsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients – methodsLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
February 2018
Biomarkers of exposure specific to e-vapor products based on stable-isotope labeled ingredientsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N SRNT 2018, Baltimore, USA
publication
March 2022
Assessment of nicotine delivery and uptake in users of various tobacco / nicotine productsScherer G, Mütze J, Pluym N, Scherer M Current Research in Toxicology, Volume 3, 100067 |
Cotinine-glucuronide | Nicotine | Urine | LC-MS/MS |
publication
March 2019
Biomarkers of Exposure Specific to E-vapor Products Based on Stable-Isotope Labeled IngredientsLandmesser A, Scherer M, Pluym N, Sarkar M, Edmiston J, Niessner R, Scherer G Nicotine & Tobacco Research, Volume 21, doi: 10.1093/ntr/nty204
publication
May 2018
Collaborative Method Performance Study of the Measurement of Nicotine, Its Metabolites, and Total Nicotine Equivalents in Human UrineWang L, Bernert JT, Benowitz NL, Feng J, Jacob P 3rd, McGahee E, Caudill SP, Scherer G, Scherer M, Pluym N, Doig MV, Newland K, Murphy SE, Caron NJ, Sander LC, Shimizu M, Yamazaki H, Kim S, Langman LJ, Pritchett JS, Sniegoski LT, Li Y, Blount BC, Pirkle JL Cancer Epidemiology, Biomarkers & Prevention, Volume 27, doi: 10.1158/1055-9965
publication
January 2014
Simple, fast and sensitive LC-MS/MS analysis for the simultaneous quantification of nicotine and 10 of its major metabolitesPiller M, Gilch G, Scherer G, Scherer M Journal of Chromatography B, Volumes 951–952, doi: 10.1016/j.jchromb.2014.01.025
Conference contribution
October 2013
Assessing the exposure to ‘smoke’ from electronic cigarettes by biomarkersScherer G, Hagedorn H-W, Riedel K, Scherer M CORESTA SSPT 2013, Seville, Spain
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–study designLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–resultsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients – methodsLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
February 2018
Biomarkers of exposure specific to e-vapor products based on stable-isotope labeled ingredientsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N SRNT 2018, Baltimore, USA
publication
March 2022
Assessment of nicotine delivery and uptake in users of various tobacco / nicotine productsScherer G, Mütze J, Pluym N, Scherer M Current Research in Toxicology, Volume 3, 100067 |
Creatinine | Normalization of urinary biomarker concentrations | Urine | Photometry | |
Cyanoethylmercapturic acid (CEMA) | Acrylonitrile | Urine | LC-MS/MS |
publication
May 2015
Analysis of 18 urinary mercapturic acids by two high-throughput multiplex-LC-MS/MS methodsPluym N, Gilch G, Scherer G, Scherer M Analytical and Bioanalytical Chemistry, Volume 407, doi: 10.1007/s00216-015-8719-x
publication
April 2014
A correlation study applied to biomarkers of internal and effective dose for acrylonitrile and 4-aminobiphenyl in smokersScherer G, Newland K, Papadopoulou E, Minet E Biomarkers, Volume 19(4), doi: 10.3109/1354750X.2014.910271
Conference contribution
October 2014
Analysis of 18 Urinary Mercapturic Acids by two Multiplex-LC-MS/MS MethodsPluym N, Gilch G, Scherer G, Scherer M CORESTA Congress 2014, Quebec, Canada
publication
October 2022
Comparison of urinary mercapturic acid excretions in users of various tobacco/nicotine productsGerhard Scherer, Nikola Pluym, Max Scherer Drug Testing and Analysis DOI: 10.1002/dta.3372 |
DHN-MA | Oxidative stress, Lipid peroxidation | Urine | LC-MS/MS |
publication
April 2018
Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature reviewScherer G Regulatory Toxicology and Pharmacology, Volume 94, doi: 10.1016/j.yrtph.2018.02.002 |
Dihydroxybutenylmercapturic acid (DHBMA) | 1,3-Butadiene | Urine | LC-MS/MS |
publication
May 2015
Analysis of 18 urinary mercapturic acids by two high-throughput multiplex-LC-MS/MS methodsPluym N, Gilch G, Scherer G, Scherer M Analytical and Bioanalytical Chemistry, Volume 407, doi: 10.1007/s00216-015-8719-x
Conference contribution
October 2014
Analysis of 18 Urinary Mercapturic Acids by two Multiplex-LC-MS/MS MethodsPluym N, Gilch G, Scherer G, Scherer M CORESTA Congress 2014, Quebec, Canada
publication
October 2022
Comparison of urinary mercapturic acid excretions in users of various tobacco/nicotine productsGerhard Scherer, Nikola Pluym, Max Scherer Drug Testing and Analysis DOI: 10.1002/dta.3372 |
Dihydroxypropylmercapturic acid (DHPMA) | Glycidol | Urine | LC-MS/MS |
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–resultsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients – methodsLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2018
Novel biomarkers to characterize exposure to aldehydes from e-vapor products based on stable-isotope constituentsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N CORESTA Congress 2018, Kunming, China
Conference contribution
October 2018
Analytical methods for the determination of carbonyls in aerosol from e-vapor products and cigarette smoke and their urinary biomarkers of exposureLandmesser A, Scherer M, Scherer G, Pluym N CORESTA Congress 2018, Kunming, China
Conference contribution
October 2019
Analysis of aldehydes, propylene oxide and glycidol in tobacco smoke and e-cigarette vapor and their respective urinary biomarkersLandmesser A, Scherer G, Pluym N, Scherer M CORESTA SSPT 2019, Hamburg, Germany
Conference contribution
February 2018
Biomarkers of exposure specific to e-vapor products based on stable-isotope labeled ingredientsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N SRNT 2018, Baltimore, USA
Conference contribution
February 2019
Novel biomarkers to characterize the specific exposure to aldehydes or epoxides from e-vapor products based on stable-isotope labeled constituentsLandmesser A, Scherer M, Scherer G, Pluym N SRNT 2019, San Francisco, USA
publication
June 2021
Assessment of the potential vaping-related exposure to carbonyls and epoxides using stable isotope-labeled precursors in the e-liquidLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Niessner R, Pluym N Archives of Toxicology, doi:10.1007/s00204-021-03097-x
publication
October 2022
Comparison of urinary mercapturic acid excretions in users of various tobacco/nicotine productsGerhard Scherer, Nikola Pluym, Max Scherer Drug Testing and Analysis DOI: 10.1002/dta.3372 |
Eugenol | Flavor | Urine | HS-SPME-GC-MS |
Conference contribution
October 2015
Determination of flavors and their metabolites in e-liquids and biological fluids - Identification of biomarkers of exposure to prominent e-cigarette flavorsRiedel K, Pluym N, Scherer G, Scherer M CORESTA SSPT 2015, Jeju, South Korea |
F-PM | Tobacco Smoke | Environmental Tobacco Smoke (ETS) | Fluorescence | |
Fromaldehyde (FA) | Tobacco Smoke, E-Vapor, Aerosol | ETS, e-liquids, aerosol | LC-MS/MS |
publication
June 2021
Assessment of the potential vaping-related exposure to carbonyls and epoxides using stable isotope-labeled precursors in the e-liquidLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Niessner R, Pluym N Archives of Toxicology, doi:10.1007/s00204-021-03097-x |
Glycerol | Glycerol | Urine, Plasma, Serum, Saliva, PBS, ETS, Aerosol, e-liquids | LC-MS/MS |
publication
March 2019
Biomarkers of Exposure Specific to E-vapor Products Based on Stable-Isotope Labeled IngredientsLandmesser A, Scherer M, Pluym N, Sarkar M, Edmiston J, Niessner R, Scherer G Nicotine & Tobacco Research, Volume 21, doi: 10.1093/ntr/nty204
Conference contribution
October 2013
Assessing the exposure to ‘smoke’ from electronic cigarettes by biomarkersScherer G, Hagedorn H-W, Riedel K, Scherer M CORESTA SSPT 2013, Seville, Spain
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–study designLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–resultsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients – methodsLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
February 2018
Biomarkers of exposure specific to e-vapor products based on stable-isotope labeled ingredientsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N SRNT 2018, Baltimore, USA |
Glycidamidemercapturic acid (GAMA) | Acrylamide | Urine | LC-MS/MS |
publication
October 2020
Benzene metabolite SPMA and acrylamide metabolites AAMA and GAMA in urine of children and adolescents in Germany - human biomonitoring results of the German Environmental Survey 2014-2017 (GerES V)Schwedler G, Murawski A, Schmied-Tobies MIH, Rucic E, Scherer M, Pluym N, Scherer G, Bethke R, Kolossa-Gehring M Environmental Research, Volume 192, doi: 10.1016/j.envres.2020.110295
publication
May 2015
Analysis of 18 urinary mercapturic acids by two high-throughput multiplex-LC-MS/MS methodsPluym N, Gilch G, Scherer G, Scherer M Analytical and Bioanalytical Chemistry, Volume 407, doi: 10.1007/s00216-015-8719-x
publication
March 2006
Urinary Mercapturic Acids and a Hemoglobin Adduct for the Dosimetry of Acrylamide Exposure in Smokers and NonsmokersUrban M, Kavvadias D, Riedel K, Scherer G, Tricker AR Inhalation Toxicology, Volume 18, doi: 10.1080/08958370600748430
Conference contribution
October 2014
Analysis of 18 Urinary Mercapturic Acids by two Multiplex-LC-MS/MS MethodsPluym N, Gilch G, Scherer G, Scherer M CORESTA Congress 2014, Quebec, Canada
publication
October 2022
Comparison of urinary mercapturic acid excretions in users of various tobacco/nicotine productsGerhard Scherer, Nikola Pluym, Max Scherer Drug Testing and Analysis DOI: 10.1002/dta.3372 |
HNA-Lactone-MA | Oxidative stress, Lipid peroxidation | Urine | LC-MS/MS |
publication
April 2018
Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature reviewScherer G Regulatory Toxicology and Pharmacology, Volume 94, doi: 10.1016/j.yrtph.2018.02.002 |
HNA-MA | Oxidative stress, Lipid peroxidation | Urine | LC-MS/MS |
publication
April 2018
Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature reviewScherer G Regulatory Toxicology and Pharmacology, Volume 94, doi: 10.1016/j.yrtph.2018.02.002 |
HNE-MA | Oxidative stress, Lipid peroxidation | Urine | LC-MS/MS |
publication
April 2018
Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature reviewScherer G Regulatory Toxicology and Pharmacology, Volume 94, doi: 10.1016/j.yrtph.2018.02.002 |
Homocysteine | Amino acid metabolism | Plasma | LC-MS/MS |
publication
January 2018
Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco productsPeck MJ, Sanders EB, Scherer G, Luedicke F, Weitkunat R Biomarkers, Volume 23(3), doi: 10.1080/1354750X.2017.1419284 |
Isoprenemercapturic acid (IPMA-3) | Isoprene | Urine | LC-MS/MS |
publication
October 2022
Comparison of urinary mercapturic acid excretions in users of various tobacco/nicotine productsGerhard Scherer, Nikola Pluym, Max Scherer Drug Testing and Analysis DOI: 10.1002/dta.3372 |
L-Carvone | Flavor | Urine | HS-SPME-GC-MS | |
Leukotriene E4 | Inflammation | Urine | LC-MS/MS |
publication
April 2018
Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature reviewScherer G Regulatory Toxicology and Pharmacology, Volume 94, doi: 10.1016/j.yrtph.2018.02.002
publication
March 2018
Analysis of Urinary Eicosanoids by LC-MS/MS Reveals Alterations in the Metabolic Profile after Smoking CessationGoettel M, Niessner R, Scherer M, Scherer G, Pluym N Chemical Research in Toxicology, Volume 31, doi: 10.1021/acs.chemrestox
publication
October 2017
Metabolomic Fingerprinting in Various Body Fluids of a Diet-Controlled Clinical Smoking Cessation Study Using a Validated GC-TOF-MS Metabolomics PlatformGoettel M, Niessner R, Mueller D, Scherer M, Scherer G, Pluym N Journal of Proteome Research, Volume 16(10), doi: 10.1021/acs.jproteome.7b00128.
publication
February 2012
A simple and robust UPLC-SRM/MS method to quantify urinary eicosanoidsSterz K, Scherer G, Ecker J Journal of Lipid Research, Volume 53, doi: 10.1194/jlr.D023739 |
Linalool | Flavor | Urine | HS-SPME-GC-MS |
Conference contribution
October 2015
Determination of flavors and their metabolites in e-liquids and biological fluids - Identification of biomarkers of exposure to prominent e-cigarette flavorsRiedel K, Pluym N, Scherer G, Scherer M CORESTA SSPT 2015, Jeju, South Korea |
MDA | Oxidative stress, lipid peroxidation | Plasma, Exhaled Breath | GC-MS |
publication
April 2018
Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature reviewScherer G Regulatory Toxicology and Pharmacology, Volume 94, doi: 10.1016/j.yrtph.2018.02.002
publication
October 2017
Metabolomic Fingerprinting in Various Body Fluids of a Diet-Controlled Clinical Smoking Cessation Study Using a Validated GC-TOF-MS Metabolomics PlatformGoettel M, Niessner R, Mueller D, Scherer M, Scherer G, Pluym N Journal of Proteome Research, Volume 16(10), doi: 10.1021/acs.jproteome.7b00128.
Conference contribution
October 2018
Identifying suitable biomarkers of biological effects (BOBEs) for evaluating reduced risk productsScherer G, Pluym N, Scherer M CORESTA Congress 2018, Biomarker Workshop, Kunming, China |
Menthol | Flavor | Urine | HS-SPME-GC-MS |
Conference contribution
October 2015
Determination of flavors and their metabolites in e-liquids and biological fluids - Identification of biomarkers of exposure to prominent e-cigarette flavorsRiedel K, Pluym N, Scherer G, Scherer M CORESTA SSPT 2015, Jeju, South Korea |
Methacrolein | Tobacco Smoke, E-Vapor Aerosol | ETS, e-liquids, aerosol | LC-MS/MS |
publication
June 2021
Assessment of the potential vaping-related exposure to carbonyls and epoxides using stable isotope-labeled precursors in the e-liquidLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Niessner R, Pluym N Archives of Toxicology, doi:10.1007/s00204-021-03097-x |
Monohydroxybutenylmercapturic acid 1 (1-MHBMA) | 1,3-Butadiene | Urine | LC-MS/MS |
publication
May 2015
Analysis of 18 urinary mercapturic acids by two high-throughput multiplex-LC-MS/MS methodsPluym N, Gilch G, Scherer G, Scherer M Analytical and Bioanalytical Chemistry, Volume 407, doi: 10.1007/s00216-015-8719-x
Conference contribution
October 2014
Analysis of 18 Urinary Mercapturic Acids by two Multiplex-LC-MS/MS MethodsPluym N, Gilch G, Scherer G, Scherer M CORESTA Congress 2014, Quebec, Canada
publication
October 2022
Comparison of urinary mercapturic acid excretions in users of various tobacco/nicotine productsGerhard Scherer, Nikola Pluym, Max Scherer Drug Testing and Analysis DOI: 10.1002/dta.3372 |
Monohydroxybutenylmercapturic acid 2 (2-MHBMA) | 1,3-Butadiene | Urine | LC-MS/MS |
publication
May 2015
Analysis of 18 urinary mercapturic acids by two high-throughput multiplex-LC-MS/MS methodsPluym N, Gilch G, Scherer G, Scherer M Analytical and Bioanalytical Chemistry, Volume 407, doi: 10.1007/s00216-015-8719-x
Conference contribution
October 2014
Analysis of 18 Urinary Mercapturic Acids by two Multiplex-LC-MS/MS MethodsPluym N, Gilch G, Scherer G, Scherer M CORESTA Congress 2014, Quebec, Canada
publication
October 2022
Comparison of urinary mercapturic acid excretions in users of various tobacco/nicotine productsGerhard Scherer, Nikola Pluym, Max Scherer Drug Testing and Analysis DOI: 10.1002/dta.3372 |
N-Nitrosoanabasine (NAB) | NAB | Urine, ETS, Aerosol | LC-MS/MS, GC-MS |
publication
December 2009
Determination of tobacco-specific N-nitrosamines in urine of smokers and non-smokersKavvadias D, Scherer G, Cheung F, Errington G, Shepperd J, McEwan M Biomarkers, Volume 14, doi: 10.3109/13547500903242883
publication
March 2009
Simultaneous determination of four tobacco-specific N-nitrosamines (TSNA) in human urineKavvadias D, Scherer G, Urban M, Cheung F, Errington G, Shepperd J, McEwan M Journal of Chromatography B, Volume 877, doi: 10.1016/j.jchromb.2009.03.009
publication
March 2022
Assessment of the Exposure to Tobacco-Specific Nitrosamines and Minor Tobacco Alkaloids in Users of Various Tobacco/Nicotine ProductsScherer G, Scherer M, Mütze J, Hauke T, Pluym N Chemical Research in Toxicology, doi: 10.1021/acs.chemrestox.2c00020 |
N-Nitrosoanatabine (NAT) | NAT | Urine, ETS, Aerosol | LC-MS/MS, GC-MS |
publication
December 2009
Determination of tobacco-specific N-nitrosamines in urine of smokers and non-smokersKavvadias D, Scherer G, Cheung F, Errington G, Shepperd J, McEwan M Biomarkers, Volume 14, doi: 10.3109/13547500903242883
publication
March 2009
Simultaneous determination of four tobacco-specific N-nitrosamines (TSNA) in human urineKavvadias D, Scherer G, Urban M, Cheung F, Errington G, Shepperd J, McEwan M Journal of Chromatography B, Volume 877, doi: 10.1016/j.jchromb.2009.03.009
publication
March 2022
Assessment of the Exposure to Tobacco-Specific Nitrosamines and Minor Tobacco Alkaloids in Users of Various Tobacco/Nicotine ProductsScherer G, Scherer M, Mütze J, Hauke T, Pluym N Chemical Research in Toxicology, doi: 10.1021/acs.chemrestox.2c00020 |
N-Nitrosonornicotine (NNN) | NNN | Urine, Plasma, Saliva, ETS, Aerosol | LC-MS/MS, GC-MS |
publication
March 2014
Saliva as a matrix for human biomonitoring in occupational and environmental medicineMichalke B, Rossbach B, Göen T, Schäferhenrich A, Scherer G International Archives of Occupational and Environmental Health, volume 88, doi: 10.1007/s00420-014-0938-5
publication
December 2009
Determination of tobacco-specific N-nitrosamines in urine of smokers and non-smokersKavvadias D, Scherer G, Cheung F, Errington G, Shepperd J, McEwan M Biomarkers, Volume 14, doi: 10.3109/13547500903242883
publication
March 2009
Simultaneous determination of four tobacco-specific N-nitrosamines (TSNA) in human urineKavvadias D, Scherer G, Urban M, Cheung F, Errington G, Shepperd J, McEwan M Journal of Chromatography B, Volume 877, doi: 10.1016/j.jchromb.2009.03.009
Conference contribution
October 2019
NNN a suitable biomarker of exposure from smoke and new nicotine delivery products?Pluym N, Taucher J, Scherer G, Scherer M CORESTA SSPT 2019, Hamburg, Germany
Conference contribution
October 2021
Quantitative analysis of NNN in plasma by LC-MS/MS: a suitable alternative to urinary determination to assess the exposure to this important toxicantPluym N, Sibul F, Jin X, Edmiston J, Sarkar M, Scherer G, Scherer M CORESTA SSPT 2021, Virtual
publication
March 2022
Assessment of the Exposure to NNN in the Plasma of Smokeless Tobacco UsersPluym N, Scherer G, Edmiston J, Jin X, Sarkar M, Scherer M Chemical Research in Toxicology, doi:10.1021/acs.chemrestox.1c00431
publication
March 2022
Assessment of the Exposure to Tobacco-Specific Nitrosamines and Minor Tobacco Alkaloids in Users of Various Tobacco/Nicotine ProductsScherer G, Scherer M, Mütze J, Hauke T, Pluym N Chemical Research in Toxicology, doi: 10.1021/acs.chemrestox.2c00020 |
NNAL | NNK (Nicotine-derived nitrosamine ketone) | Urine | LC-MS/MS |
publication
January 2018
Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco productsPeck MJ, Sanders EB, Scherer G, Luedicke F, Weitkunat R Biomarkers, Volume 23(3), doi: 10.1080/1354750X.2017.1419284
publication
December 2009
Determination of tobacco-specific N-nitrosamines in urine of smokers and non-smokersKavvadias D, Scherer G, Cheung F, Errington G, Shepperd J, McEwan M Biomarkers, Volume 14, doi: 10.3109/13547500903242883
publication
March 2009
Simultaneous determination of four tobacco-specific N-nitrosamines (TSNA) in human urineKavvadias D, Scherer G, Urban M, Cheung F, Errington G, Shepperd J, McEwan M Journal of Chromatography B, Volume 877, doi: 10.1016/j.jchromb.2009.03.009
publication
March 2022
Assessment of the Exposure to Tobacco-Specific Nitrosamines and Minor Tobacco Alkaloids in Users of Various Tobacco/Nicotine ProductsScherer G, Scherer M, Mütze J, Hauke T, Pluym N Chemical Research in Toxicology, doi: 10.1021/acs.chemrestox.2c00020 |
NNK | Tobacco Smoke, Aerosol | ETS, Aerosol | LC-MS/MS | |
Nicotine (Nic) | Nicotine | Urine, Plasma, Serum, Saliva, PBS, ETS, e-liquids, aerosol | LC-MS/MS, GC-MS |
publication
March 2019
Biomarkers of Exposure Specific to E-vapor Products Based on Stable-Isotope Labeled IngredientsLandmesser A, Scherer M, Pluym N, Sarkar M, Edmiston J, Niessner R, Scherer G Nicotine & Tobacco Research, Volume 21, doi: 10.1093/ntr/nty204
publication
May 2018
Collaborative Method Performance Study of the Measurement of Nicotine, Its Metabolites, and Total Nicotine Equivalents in Human UrineWang L, Bernert JT, Benowitz NL, Feng J, Jacob P 3rd, McGahee E, Caudill SP, Scherer G, Scherer M, Pluym N, Doig MV, Newland K, Murphy SE, Caron NJ, Sander LC, Shimizu M, Yamazaki H, Kim S, Langman LJ, Pritchett JS, Sniegoski LT, Li Y, Blount BC, Pirkle JL Cancer Epidemiology, Biomarkers & Prevention, Volume 27, doi: 10.1158/1055-9965
publication
March 2014
Saliva as a matrix for human biomonitoring in occupational and environmental medicineMichalke B, Rossbach B, Göen T, Schäferhenrich A, Scherer G International Archives of Occupational and Environmental Health, volume 88, doi: 10.1007/s00420-014-0938-5
publication
January 2014
Simple, fast and sensitive LC-MS/MS analysis for the simultaneous quantification of nicotine and 10 of its major metabolitesPiller M, Gilch G, Scherer G, Scherer M Journal of Chromatography B, Volumes 951–952, doi: 10.1016/j.jchromb.2014.01.025
Conference contribution
October 2013
Assessing the exposure to ‘smoke’ from electronic cigarettes by biomarkersScherer G, Hagedorn H-W, Riedel K, Scherer M CORESTA SSPT 2013, Seville, Spain
Conference contribution
October 2016
Ultra-sensitive method for the determination of nicotine in PK studies with next generation productsWanderer F, Pluym N, Scherer G, Scherer M CORESTA Congress 2016, Berlin, Germany
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–study designLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–resultsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients – methodsLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
February 2018
Biomarkers of exposure specific to e-vapor products based on stable-isotope labeled ingredientsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N SRNT 2018, Baltimore, USA
publication
March 2022
Assessment of nicotine delivery and uptake in users of various tobacco / nicotine productsScherer G, Mütze J, Pluym N, Scherer M Current Research in Toxicology, Volume 3, 100067 |
Nicotine-N-oxide (NNO) | Nicotine | Urine | LC-MS/MS |
publication
March 2019
Biomarkers of Exposure Specific to E-vapor Products Based on Stable-Isotope Labeled IngredientsLandmesser A, Scherer M, Pluym N, Sarkar M, Edmiston J, Niessner R, Scherer G Nicotine & Tobacco Research, Volume 21, doi: 10.1093/ntr/nty204
publication
May 2018
Collaborative Method Performance Study of the Measurement of Nicotine, Its Metabolites, and Total Nicotine Equivalents in Human UrineWang L, Bernert JT, Benowitz NL, Feng J, Jacob P 3rd, McGahee E, Caudill SP, Scherer G, Scherer M, Pluym N, Doig MV, Newland K, Murphy SE, Caron NJ, Sander LC, Shimizu M, Yamazaki H, Kim S, Langman LJ, Pritchett JS, Sniegoski LT, Li Y, Blount BC, Pirkle JL Cancer Epidemiology, Biomarkers & Prevention, Volume 27, doi: 10.1158/1055-9965
publication
January 2014
Simple, fast and sensitive LC-MS/MS analysis for the simultaneous quantification of nicotine and 10 of its major metabolitesPiller M, Gilch G, Scherer G, Scherer M Journal of Chromatography B, Volumes 951–952, doi: 10.1016/j.jchromb.2014.01.025
Conference contribution
October 2013
Assessing the exposure to ‘smoke’ from electronic cigarettes by biomarkersScherer G, Hagedorn H-W, Riedel K, Scherer M CORESTA SSPT 2013, Seville, Spain
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–study designLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–resultsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients – methodsLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
February 2018
Biomarkers of exposure specific to e-vapor products based on stable-isotope labeled ingredientsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N SRNT 2018, Baltimore, USA
publication
March 2022
Assessment of nicotine delivery and uptake in users of various tobacco / nicotine productsScherer G, Mütze J, Pluym N, Scherer M Current Research in Toxicology, Volume 3, 100067 |
Nicotine-glucuronide (Nic-gluc) | Nicotine | Urine | LC-MS/MS |
publication
March 2019
Biomarkers of Exposure Specific to E-vapor Products Based on Stable-Isotope Labeled IngredientsLandmesser A, Scherer M, Pluym N, Sarkar M, Edmiston J, Niessner R, Scherer G Nicotine & Tobacco Research, Volume 21, doi: 10.1093/ntr/nty204
publication
May 2018
Collaborative Method Performance Study of the Measurement of Nicotine, Its Metabolites, and Total Nicotine Equivalents in Human UrineWang L, Bernert JT, Benowitz NL, Feng J, Jacob P 3rd, McGahee E, Caudill SP, Scherer G, Scherer M, Pluym N, Doig MV, Newland K, Murphy SE, Caron NJ, Sander LC, Shimizu M, Yamazaki H, Kim S, Langman LJ, Pritchett JS, Sniegoski LT, Li Y, Blount BC, Pirkle JL Cancer Epidemiology, Biomarkers & Prevention, Volume 27, doi: 10.1158/1055-9965
publication
January 2014
Simple, fast and sensitive LC-MS/MS analysis for the simultaneous quantification of nicotine and 10 of its major metabolitesPiller M, Gilch G, Scherer G, Scherer M Journal of Chromatography B, Volumes 951–952, doi: 10.1016/j.jchromb.2014.01.025
Conference contribution
October 2013
Assessing the exposure to ‘smoke’ from electronic cigarettes by biomarkersScherer G, Hagedorn H-W, Riedel K, Scherer M CORESTA SSPT 2013, Seville, Spain
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–study designLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–resultsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients – methodsLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
February 2018
Biomarkers of exposure specific to e-vapor products based on stable-isotope labeled ingredientsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N SRNT 2018, Baltimore, USA
publication
March 2022
Assessment of nicotine delivery and uptake in users of various tobacco / nicotine productsScherer G, Mütze J, Pluym N, Scherer M Current Research in Toxicology, Volume 3, 100067 |
Norcotinine | Nicotine | Urine | LC-MS/MS |
publication
March 2019
Biomarkers of Exposure Specific to E-vapor Products Based on Stable-Isotope Labeled IngredientsLandmesser A, Scherer M, Pluym N, Sarkar M, Edmiston J, Niessner R, Scherer G Nicotine & Tobacco Research, Volume 21, doi: 10.1093/ntr/nty204
publication
May 2018
Collaborative Method Performance Study of the Measurement of Nicotine, Its Metabolites, and Total Nicotine Equivalents in Human UrineWang L, Bernert JT, Benowitz NL, Feng J, Jacob P 3rd, McGahee E, Caudill SP, Scherer G, Scherer M, Pluym N, Doig MV, Newland K, Murphy SE, Caron NJ, Sander LC, Shimizu M, Yamazaki H, Kim S, Langman LJ, Pritchett JS, Sniegoski LT, Li Y, Blount BC, Pirkle JL Cancer Epidemiology, Biomarkers & Prevention, Volume 27, doi: 10.1158/1055-9965
publication
January 2014
Simple, fast and sensitive LC-MS/MS analysis for the simultaneous quantification of nicotine and 10 of its major metabolitesPiller M, Gilch G, Scherer G, Scherer M Journal of Chromatography B, Volumes 951–952, doi: 10.1016/j.jchromb.2014.01.025
Conference contribution
October 2013
Assessing the exposure to ‘smoke’ from electronic cigarettes by biomarkersScherer G, Hagedorn H-W, Riedel K, Scherer M CORESTA SSPT 2013, Seville, Spain
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–study designLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–resultsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients – methodsLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
February 2018
Biomarkers of exposure specific to e-vapor products based on stable-isotope labeled ingredientsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N SRNT 2018, Baltimore, USA
publication
March 2022
Assessment of nicotine delivery and uptake in users of various tobacco / nicotine productsScherer G, Mütze J, Pluym N, Scherer M Current Research in Toxicology, Volume 3, 100067 |
Nornicotine | Nicotine | Urine | LC-MS/MS |
publication
March 2019
Biomarkers of Exposure Specific to E-vapor Products Based on Stable-Isotope Labeled IngredientsLandmesser A, Scherer M, Pluym N, Sarkar M, Edmiston J, Niessner R, Scherer G Nicotine & Tobacco Research, Volume 21, doi: 10.1093/ntr/nty204
publication
May 2018
Collaborative Method Performance Study of the Measurement of Nicotine, Its Metabolites, and Total Nicotine Equivalents in Human UrineWang L, Bernert JT, Benowitz NL, Feng J, Jacob P 3rd, McGahee E, Caudill SP, Scherer G, Scherer M, Pluym N, Doig MV, Newland K, Murphy SE, Caron NJ, Sander LC, Shimizu M, Yamazaki H, Kim S, Langman LJ, Pritchett JS, Sniegoski LT, Li Y, Blount BC, Pirkle JL Cancer Epidemiology, Biomarkers & Prevention, Volume 27, doi: 10.1158/1055-9965
publication
January 2014
Simple, fast and sensitive LC-MS/MS analysis for the simultaneous quantification of nicotine and 10 of its major metabolitesPiller M, Gilch G, Scherer G, Scherer M Journal of Chromatography B, Volumes 951–952, doi: 10.1016/j.jchromb.2014.01.025
Conference contribution
October 2013
Assessing the exposure to ‘smoke’ from electronic cigarettes by biomarkersScherer G, Hagedorn H-W, Riedel K, Scherer M CORESTA SSPT 2013, Seville, Spain
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–study designLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–resultsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients – methodsLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
February 2018
Biomarkers of exposure specific to e-vapor products based on stable-isotope labeled ingredientsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N SRNT 2018, Baltimore, USA
publication
March 2022
Assessment of nicotine delivery and uptake in users of various tobacco / nicotine productsScherer G, Mütze J, Pluym N, Scherer M Current Research in Toxicology, Volume 3, 100067 |
PGF2α | Oxidative Stress | Urine | LC-MS/MS |
publication
April 2018
Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature reviewScherer G Regulatory Toxicology and Pharmacology, Volume 94, doi: 10.1016/j.yrtph.2018.02.002
publication
March 2018
Analysis of Urinary Eicosanoids by LC-MS/MS Reveals Alterations in the Metabolic Profile after Smoking CessationGoettel M, Niessner R, Scherer M, Scherer G, Pluym N Chemical Research in Toxicology, Volume 31, doi: 10.1021/acs.chemrestox
publication
October 2017
Metabolomic Fingerprinting in Various Body Fluids of a Diet-Controlled Clinical Smoking Cessation Study Using a Validated GC-TOF-MS Metabolomics PlatformGoettel M, Niessner R, Mueller D, Scherer M, Scherer G, Pluym N Journal of Proteome Research, Volume 16(10), doi: 10.1021/acs.jproteome.7b00128.
publication
February 2012
A simple and robust UPLC-SRM/MS method to quantify urinary eicosanoidsSterz K, Scherer G, Ecker J Journal of Lipid Research, Volume 53, doi: 10.1194/jlr.D023739 |
Particulate matter (PM) | Tobacco Smoke | Environmental Tobacco Smoke (ETS) | Light scattering or gravimetry | |
Phenantrene (Phe) | PAH | ETS | GC-MS | |
Propionaldehyde (PA) | Tobacco Smoke, E-Vapor Aerosol | ETS, e-liquids, aerosol | LC-MS/MS |
publication
June 2021
Assessment of the potential vaping-related exposure to carbonyls and epoxides using stable isotope-labeled precursors in the e-liquidLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Niessner R, Pluym N Archives of Toxicology, doi:10.1007/s00204-021-03097-x |
Propylene glycol (PG) | Propylene glycol | Urine, Plasma, Serum, Saliva, PBS, Aerosol, ETS, e-liquids | LC-MS/MS |
publication
March 2019
Biomarkers of Exposure Specific to E-vapor Products Based on Stable-Isotope Labeled IngredientsLandmesser A, Scherer M, Pluym N, Sarkar M, Edmiston J, Niessner R, Scherer G Nicotine & Tobacco Research, Volume 21, doi: 10.1093/ntr/nty204
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–resultsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N CORESTA SSPT 2017, Kitzbühel, Austria
publication
October 2021
1,2-Propylene Glycol: A Biomarker of Exposure Specific to e-Cigarette ConsumptionBurkhardt T, Pluym N, Scherer G, Scherer M Separations, 8, 180, doi: 10.3390/separations8100180
Conference contribution
March 2022
Propylene glycol: A Biomarker of Exposure specific to E-Cigarette ConsumptionBurkhardt T, Pluym N, Scherer G, Scherer M SRNT 2022, Baltimore (Hybrid), USA
Conference contribution
September 2022
Propylene glycol as a specific biomarker for e-cigarette use Showcase of a novel Orbitrap-MS-based exposomics approachNikola Pluym, Therese Burkhardt, Alpesh Kachhadia, Gerhard Scherer, Max Scherer ISES 2022, Lisbon |
Prostaglandin D | Oxidative Stress | Urine | LC-MS/MS |
publication
April 2018
Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature reviewScherer G Regulatory Toxicology and Pharmacology, Volume 94, doi: 10.1016/j.yrtph.2018.02.002
publication
March 2018
Analysis of Urinary Eicosanoids by LC-MS/MS Reveals Alterations in the Metabolic Profile after Smoking CessationGoettel M, Niessner R, Scherer M, Scherer G, Pluym N Chemical Research in Toxicology, Volume 31, doi: 10.1021/acs.chemrestox
publication
October 2017
Metabolomic Fingerprinting in Various Body Fluids of a Diet-Controlled Clinical Smoking Cessation Study Using a Validated GC-TOF-MS Metabolomics PlatformGoettel M, Niessner R, Mueller D, Scherer M, Scherer G, Pluym N Journal of Proteome Research, Volume 16(10), doi: 10.1021/acs.jproteome.7b00128.
publication
February 2012
A simple and robust UPLC-SRM/MS method to quantify urinary eicosanoidsSterz K, Scherer G, Ecker J Journal of Lipid Research, Volume 53, doi: 10.1194/jlr.D023739 |
Prostaglandin E | Oxidative Stress | Urine | LC-MS/MS |
publication
April 2018
Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature reviewScherer G Regulatory Toxicology and Pharmacology, Volume 94, doi: 10.1016/j.yrtph.2018.02.002
publication
March 2018
Analysis of Urinary Eicosanoids by LC-MS/MS Reveals Alterations in the Metabolic Profile after Smoking CessationGoettel M, Niessner R, Scherer M, Scherer G, Pluym N Chemical Research in Toxicology, Volume 31, doi: 10.1021/acs.chemrestox
publication
October 2017
Metabolomic Fingerprinting in Various Body Fluids of a Diet-Controlled Clinical Smoking Cessation Study Using a Validated GC-TOF-MS Metabolomics PlatformGoettel M, Niessner R, Mueller D, Scherer M, Scherer G, Pluym N Journal of Proteome Research, Volume 16(10), doi: 10.1021/acs.jproteome.7b00128.
publication
February 2012
A simple and robust UPLC-SRM/MS method to quantify urinary eicosanoidsSterz K, Scherer G, Ecker J Journal of Lipid Research, Volume 53, doi: 10.1194/jlr.D023739 |
Pyrene (Pyr) | PAH | ETS | GC-MS | |
S-Benzylmercapturic acid (SBMA) | Toluene | Urine | LC-MS/MS |
publication
May 2015
Analysis of 18 urinary mercapturic acids by two high-throughput multiplex-LC-MS/MS methodsPluym N, Gilch G, Scherer G, Scherer M Analytical and Bioanalytical Chemistry, Volume 407, doi: 10.1007/s00216-015-8719-x
Conference contribution
October 2014
Analysis of 18 Urinary Mercapturic Acids by two Multiplex-LC-MS/MS MethodsPluym N, Gilch G, Scherer G, Scherer M CORESTA Congress 2014, Quebec, Canada
publication
October 2022
Comparison of urinary mercapturic acid excretions in users of various tobacco/nicotine productsGerhard Scherer, Nikola Pluym, Max Scherer Drug Testing and Analysis DOI: 10.1002/dta.3372 |
S-Phenylmercapturic acid (SPMA) | Benzene | Urine | LC-MS/MS |
publication
October 2020
Benzene metabolite SPMA and acrylamide metabolites AAMA and GAMA in urine of children and adolescents in Germany - human biomonitoring results of the German Environmental Survey 2014-2017 (GerES V)Schwedler G, Murawski A, Schmied-Tobies MIH, Rucic E, Scherer M, Pluym N, Scherer G, Bethke R, Kolossa-Gehring M Environmental Research, Volume 192, doi: 10.1016/j.envres.2020.110295
publication
May 2015
Analysis of 18 urinary mercapturic acids by two high-throughput multiplex-LC-MS/MS methodsPluym N, Gilch G, Scherer G, Scherer M Analytical and Bioanalytical Chemistry, Volume 407, doi: 10.1007/s00216-015-8719-x
Conference contribution
October 2014
Analysis of 18 Urinary Mercapturic Acids by two Multiplex-LC-MS/MS MethodsPluym N, Gilch G, Scherer G, Scherer M CORESTA Congress 2014, Quebec, Canada
publication
October 2022
Comparison of urinary mercapturic acid excretions in users of various tobacco/nicotine productsGerhard Scherer, Nikola Pluym, Max Scherer Drug Testing and Analysis DOI: 10.1002/dta.3372 |
Solanesol | Tobacco Smoke | Environmental Tobacco Smoke (ETS) | LC-MS | |
Toluene | Tobacco Smoke | ETS | GC-MS | |
Trehalose | Trehalose | PBS | LC-MS/MS | |
UV-PM | Tobacco Smoke | Environmental Tobacco Smoke (ETS) | Photometry | |
Xylene | Tobacco Smoke | ETS | GC-MS | |
ortho-Toluidine | ortho-Toluidine | Urine, ETS | GC-MS |
publication
April 2006
Determination of three carcinogenic aromatic amines in urine of smokers and nonsmokersRiedel K, Scherer G, Engl J, Hagedorn H-W, Tricker AR Journal of Analytical Toxicology, Volume 30, doi: 10.1093/jat/30.3.187
publication
November 2022
Assessment of the Exposure to Aromatic Amines in Users of Various Tobacco/Nicotine ProductsGerhard Scherer, Kirsten Riedel, Nikola Pluym, Max Scherer ACS Omega, doi: 10.1021/acsomega.2c06130 |
para-Menthane-3,8-diol | Menthol | Plasma, Serum | LC-MS/MS |
Conference contribution
October 2015
Determination of flavors and their metabolites in e-liquids and biological fluids - Identification of biomarkers of exposure to prominent e-cigarette flavorsRiedel K, Pluym N, Scherer G, Scherer M CORESTA SSPT 2015, Jeju, South Korea |
sICAM-1 | Inflammation | Plasma | ELISA | |
trans,trans-muconic acid (tt-MA) | Benzene | Urine | GC-MS | |
trans-3'-Hydroxycotinine (3-OH-Cot) | Nicotine | Urine, Plasma, Serum, Saliva | LC-MS/MS |
publication
March 2019
Biomarkers of Exposure Specific to E-vapor Products Based on Stable-Isotope Labeled IngredientsLandmesser A, Scherer M, Pluym N, Sarkar M, Edmiston J, Niessner R, Scherer G Nicotine & Tobacco Research, Volume 21, doi: 10.1093/ntr/nty204
publication
May 2018
Collaborative Method Performance Study of the Measurement of Nicotine, Its Metabolites, and Total Nicotine Equivalents in Human UrineWang L, Bernert JT, Benowitz NL, Feng J, Jacob P 3rd, McGahee E, Caudill SP, Scherer G, Scherer M, Pluym N, Doig MV, Newland K, Murphy SE, Caron NJ, Sander LC, Shimizu M, Yamazaki H, Kim S, Langman LJ, Pritchett JS, Sniegoski LT, Li Y, Blount BC, Pirkle JL Cancer Epidemiology, Biomarkers & Prevention, Volume 27, doi: 10.1158/1055-9965
publication
March 2014
Saliva as a matrix for human biomonitoring in occupational and environmental medicineMichalke B, Rossbach B, Göen T, Schäferhenrich A, Scherer G International Archives of Occupational and Environmental Health, volume 88, doi: 10.1007/s00420-014-0938-5
publication
January 2014
Simple, fast and sensitive LC-MS/MS analysis for the simultaneous quantification of nicotine and 10 of its major metabolitesPiller M, Gilch G, Scherer G, Scherer M Journal of Chromatography B, Volumes 951–952, doi: 10.1016/j.jchromb.2014.01.025
publication
February 2014
Untargeted metabolomic profiling in saliva of smokers and nonsmokers by a validated GC-TOF-MS methodMueller DC, Piller M, Niessner R, Scherer M, Scherer G Journal of Proteome Research, Volume 13, doi: 10.1021/pr401099r
Conference contribution
October 2013
Assessing the exposure to ‘smoke’ from electronic cigarettes by biomarkersScherer G, Hagedorn H-W, Riedel K, Scherer M CORESTA SSPT 2013, Seville, Spain
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–study designLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–resultsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients – methodsLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
February 2018
Biomarkers of exposure specific to e-vapor products based on stable-isotope labeled ingredientsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N SRNT 2018, Baltimore, USA
publication
March 2022
Assessment of nicotine delivery and uptake in users of various tobacco / nicotine productsScherer G, Mütze J, Pluym N, Scherer M Current Research in Toxicology, Volume 3, 100067 |
trans-3'-Hydroxycotinine-glucuronide (3-OH-Cot-gluc) | Nicotine | Urine | LC-MS/MS |
publication
March 2019
Biomarkers of Exposure Specific to E-vapor Products Based on Stable-Isotope Labeled IngredientsLandmesser A, Scherer M, Pluym N, Sarkar M, Edmiston J, Niessner R, Scherer G Nicotine & Tobacco Research, Volume 21, doi: 10.1093/ntr/nty204
publication
May 2018
Collaborative Method Performance Study of the Measurement of Nicotine, Its Metabolites, and Total Nicotine Equivalents in Human UrineWang L, Bernert JT, Benowitz NL, Feng J, Jacob P 3rd, McGahee E, Caudill SP, Scherer G, Scherer M, Pluym N, Doig MV, Newland K, Murphy SE, Caron NJ, Sander LC, Shimizu M, Yamazaki H, Kim S, Langman LJ, Pritchett JS, Sniegoski LT, Li Y, Blount BC, Pirkle JL Cancer Epidemiology, Biomarkers & Prevention, Volume 27, doi: 10.1158/1055-9965
publication
January 2014
Simple, fast and sensitive LC-MS/MS analysis for the simultaneous quantification of nicotine and 10 of its major metabolitesPiller M, Gilch G, Scherer G, Scherer M Journal of Chromatography B, Volumes 951–952, doi: 10.1016/j.jchromb.2014.01.025
Conference contribution
October 2013
Assessing the exposure to ‘smoke’ from electronic cigarettes by biomarkersScherer G, Hagedorn H-W, Riedel K, Scherer M CORESTA SSPT 2013, Seville, Spain
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–study designLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–resultsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017
Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients – methodsLandmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
February 2018
Biomarkers of exposure specific to e-vapor products based on stable-isotope labeled ingredientsLandmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N SRNT 2018, Baltimore, USA
publication
March 2022
Assessment of nicotine delivery and uptake in users of various tobacco / nicotine productsScherer G, Mütze J, Pluym N, Scherer M Current Research in Toxicology, Volume 3, 100067 |
Frequently searched biomarkers